L Goetsch
Overview
Explore the profile of L Goetsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
2157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beck A, Goetsch L, Champion T, Bussat M, Aubry J, Klinguer-Hamour C, et al.
Biologicals
. 2002 Feb;
29(3-4):293-8.
PMID: 11851331
The decapeptide ELA (ELAGIGILTV), a Melan-A/MART-1 antigen immunodominant peptide analogue, is an interesting melanoma vaccine candidate alone or in combination with other tumour antigens. P40, the recombinant outer membrane protein...
2.
Goetsch L, Gonzalez A, Haeuw J, Aubry J, Beck A, Bonnefoy J, et al.
Infect Immun
. 2001 Sep;
69(10):6434-44.
PMID: 11553588
Administration of vaccines by the nasal route has recently proven to be one of the most efficient ways for inducing both mucosal and systemic antibody responses in experimental animals. Our...
3.
Beck A, Bussat M, Klinguer-Hamour C, Goetsch L, Aubry J, Champion T, et al.
J Pept Res
. 2001 Jul;
57(6):528-38.
PMID: 11437956
Several cytotoxic T lymphocyte peptide-based vaccines against hepatitis B, human immunodeficiency virus and melanoma were recently studied in clinical trials. One interesting melanoma vaccine candidate alone or in combination with...
4.
Goetsch L, Aubry J, Haeuw J, Bonnefoy J, Nguyen N, Corvaia N, et al.
Vaccine
. 2001 Jun;
19(28-29):4036-42.
PMID: 11427280
Respiratory syncytial virus (RSV) is a major respiratory pathogen responsible for severe pulmonary disease. We have developed a parenterally administered vaccine, BBG2Na, which is currently in a phase III clinical...
5.
Jeannin P, Renno T, Goetsch L, Miconnet I, Aubry J, Delneste Y, et al.
Nat Immunol
. 2001 Mar;
1(6):502-9.
PMID: 11101872
We analyzed the interaction between a bacterial cell wall protein and dendritic cells (DCs). Outer membrane protein A from Klebsiella pneumoniae (kpOmpA) specifically bound to professional antigen presenting cells and...
6.
Power U, Goetsch L, Champion T, Beck A, Haeuw J, Nguyen T, et al.
Vaccine
. 2001 Mar;
19(17-19):2345-51.
PMID: 11257359
Respiratory syncytial virus (RSV) is an important respiratory pathogen in man, against which no vaccine is available. However, recent evidence suggests that antibodies to the RSV F and G proteins...
7.
Haeuw J, Libon C, Zanna L, Goetsch L, Champion T, Nguyen T, et al.
Dev Biol (Basel)
. 2001 Feb;
103:245-50.
PMID: 11214244
No abstract available.
8.
Jeannin P, Magistrelli G, Aubry J, Caron G, Gauchat J, Renno T, et al.
Immunity
. 2000 Oct;
13(3):303-12.
PMID: 11021528
CD86 is an important costimulatory molecule for the priming and activation of naive and memory T cells, respectively. Here, we show that soluble CD86 is detected in human serum. Soluble...
9.
Goetsch L, Champion T, Beck A, Corvaia N, Stahl S, Bonnefoy J, et al.
Vaccine
. 2000 Apr;
18(24):2735-42.
PMID: 10781861
The immunogenicity and protective efficacy of BBG2Na, a novel recombinant respiratory syncytial virus subunit vaccine candidate, was assessed in BALB/c mice under various conditions of dose, administration route and number...
10.
Rauly I, Goetsch L, Haeuw J, Tardieux C, Baussant T, Bonnefoy J, et al.
Infect Immun
. 1999 Oct;
67(11):5547-51.
PMID: 10531198
We have recently cloned a new protein, recombinant P40 (rP40). When tested in vivo after conjugation to a B-cell epitope, rP40 induces an important antibody response without the need for...